USC removes name of Rufus von KleinSmid, a eugenics leader, from prominent building
By Teresa Watanabe and Tomás Mier,
Los Angeles Times
| 06. 12. 2020
The scholar, who is credited with expanding the university’s academic programs and international relations curriculum as president from 1921 to 1947, believed that people with “defects” had no ethical right to parenthood and should be sterilized.
With its soaring arches, international flags and globe-topped tower, the Von KleinSmid Center for International and Public Affairs is one of the most prominent buildings at USC. Its namesake, the late Rufus B. von KleinSmid, has held a place of distinction as the university’s fifth president.
But on Thursday, USC announced it had stripped Von KleinSmid’s name from the building as the university at last reconciled with his disturbing leadership role in California’s eugenics movement.
The scholar, who is credited with expanding the university’s academic programs and international relations curriculum as president from 1921 to 1947, believed that people with “defects” had no ethical right to parenthood and should be sterilized. His “Human Betterment Foundation” was instrumental in supporting the 1909 California legislation that authorized the forced sterilization of those deemed “unfit” — essentially anyone non-white, said Alexandra Minna Stern, a University of Michigan history professor and expert on eugenics.
His active support of eugenics is “at direct odds with USC’s multicultural community and our mission of diversity and inclusion,” President Carol L. Folt announced.
“This moment is our Call...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...
